UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis

Circulation (New York, N.Y.), 2003-12, Vol.108 (24), p.2957-2963

2003

Volltextzugriff (PDF)

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2004-06, Vol.363 (9426), p.2015-2021

2004

Volltextzugriff (PDF)

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

Annals of the rheumatic diseases, 2007-02, Vol.66 (2), p.235-241

2007

Volltextzugriff (PDF)

The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population

Journal of rheumatology, 2006-07, Vol.33 (7), p.1254

2006

Volltextzugriff (PDF)

Nonsteroidal antiinflammatory drug withdrawal in patients with stable rheumatoid arthritis

Journal of rheumatology, 2011-10, Vol.38 (10), p.2150-2152

2011

Volltextzugriff (PDF)

Physician... Attorney of the poor

Journal of rheumatology, 2007-12, Vol.34 (12), p.2320

2007

Volltextzugriff (PDF)

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2017-04, Vol.76 (4), p.654-660

2017

Volltextzugriff (PDF)

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Rheumatology (Oxford, England), 2011-01, Vol.50 (1), p.124-131

2011

Volltextzugriff (PDF)

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

The Lancet (British edition), 2004-07, Vol.364 (9430), p.263-269

2004

Volltextzugriff (PDF)

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

Annals of the rheumatic diseases, 2010-03, Vol.69 (3), p.522-528

2010

Volltextzugriff (PDF)

A Longitudinal Study of Lung Function in Nonsmoking Patients With Rheumatoid Arthritis

Chest, 2003-10, Vol.124 (4), p.1224-1231

2003

Volltextzugriff (PDF)

Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2021-10, Vol.73 (10), p.1800-1809

2021

Volltextzugriff (PDF)

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients

Rheumatology (Oxford, England), 2019-12, Vol.58 (12), p.2162-2169

2019

Volltextzugriff (PDF)

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

Annals of the rheumatic diseases, 2009-02, Vol.68 (2), p.209-215

2009

Volltextzugriff (PDF)

Another DMARD option in rheumatoid arthritis?

Journal of rheumatology, 2003-10, Vol.30 (10), p.2085

2003

Volltextzugriff (PDF)

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

Arthritis care & research (2010), 2010-06, Vol.62 (6), p.755-763

2010

Volltextzugriff (PDF)

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

Annals of the rheumatic diseases, 2010-06, Vol.69 (6), p.1086-1091

2010

Volltextzugriff (PDF)

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

Rheumatology (Oxford, England), 2016-11, Vol.55 (11), p.2033-2039

2016

Volltextzugriff (PDF)

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

Annals of the rheumatic diseases, 2012-06, Vol.71 (6), p.869-874

2012

Volltextzugriff (PDF)

Recent advances: rheumatology

BMJ (Online), 2000-10, Vol.321 (7265), p.882-885

International edition, 2000

Volltextzugriff (PDF)

Improved medical and surgical management of cervical spine disease in patients with rheumatoid arthritis over 10 years

Annals of the rheumatic diseases, 2000-06, Vol.59 (6), p.434-438

2000

Volltextzugriff (PDF)

Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs

Nature clinical practice. Rheumatology, 2007-08, Vol.3 (8), p.450-458

2007

Volltextzugriff (PDF)

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Rheumatology (Oxford, England), 2020-03, Vol.59 (3), p.559-567

2020

Volltextzugriff (PDF)

Long-term persistence with rituximab in patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2018-06, Vol.57 (6), p.1089-1096

2018

Volltextzugriff (PDF)

"5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy

Journal of rheumatology, 2002-10, Vol.29 (10), p.2099

2002

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(74)
magazinearticle
(1)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Humans
(61)
Science & Technology
(55)
Life Sciences & Biomedicine
(54)
Arthritis, Rheumatoid - Drug Therapy
(42)
Female
(40)
Rheumatology
(40)
Middle Aged
(37)
Rheumatoid Arthritis
(35)
Male
(34)
Biological And Medical Sciences
(31)
Medical Sciences
(31)
Aged
(28)
Adult
(25)
Antirheumatic Agents - Therapeutic Use
(24)
Diseases Of The Osteoarticular System
(20)
Inflammatory Joint Diseases
(18)
Antirheumatic Agents - Adverse Effects
(12)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(12)
General & Internal Medicine
(11)
Pharmacology. Drug Treatments
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Explaining how high-grade systemic inflammation accelerates vascular risk in rheumatoid arthritis

Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial

Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study

The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population

Nonsteroidal antiinflammatory drug withdrawal in patients with stable rheumatoid arthritis

Physician... Attorney of the poor

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

A Longitudinal Study of Lung Function in Nonsmoking Patients With Rheumatoid Arthritis

Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor α therapy: results from the British Society for Rheumatology Biologics Register

Another DMARD option in rheumatoid arthritis?

Influence of anti–tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: Results from the British Society for rheumatology biologics register

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

Recent advances: rheumatology

Improved medical and surgical management of cervical spine disease in patients with rheumatoid arthritis over 10 years

Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

Long-term persistence with rituximab in patients with rheumatoid arthritis

"5D" Outcome in 52 patients with rheumatoid arthritis surviving 20 years after initial disease modifying antirheumatic drug therapy

Suchergebnisse filtern